Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-30 @ 3:18 AM
Study NCT ID:
NCT07463651
Status:
RECRUITING
Last Update Posted:
2026-03-20
First Post:
2026-02-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib
Sponsor:
The First Affiliated Hospital of Soochow University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TROPHY-15
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None